Data in this article presents the results of conventional cytogenetics and fluorescence in situ hybridization (FISH) analyses in 129 patients with confirmed MECOM rearrangement (https://doi.org/ 10.1016/j.cancergen.2019.03.002) [1] . Generally, the MECOM rearrangement has arisen through translocation, inversion, and insertion and/or unknown mechanism. In addition to the typical chromosomal aberrations, inv(3)(q21q26.2) and t(3; 3)(q21; q26. 6) [2e4], over 50% of cases presented here exhibit a wide spectrum of MECOM rearrangement-driven, atypical chromosomal aberrations, including inv(3) with breakpoint other than 3q21; t(1; 3); t(2; 3); t(3; 6); t(3; 8); t(3; 12); t(3; 17); t(3; 21) as well as an insertion of 3q26.2 into different chromosomes. These cases are thoroughly characterized by karyotyping, interphase-, metaphase-, map-back FISH and whole chromosomal painting (WCP) analyses.
This is an intensive characterization of complexities of chromosomal aberrations involving 3q26.2/ MECOM rearrangement in 129 cases with a variety of myeloid malignancies. The majority of cases with atypical and/or complex karyotype has been thoroughly analyzed by interphase-, metaphase-, mapback FISH, and/or whole chromosome painting (WCP). In addition to the results of conventional cytogenetics and FISH analyses, other general clinical information including age, gender, pathologic diagnosis and outcomes, are also included (Table 1) . We believe that all these cases can be practically useful for scientists and/or pathologists in the field of cytogenetic and genomic diagnostics. They can be used as references for all newly encountered case with a putative 3q26.2 abnormality/MECOM rearrangement.
Experimental design, materials and methods
This is a retrospective study. A search of the cytogenetics database for MECOM FISH positive cases from May 1, 2009 to August 15, 2018 at The University of Texas MD Anderson Cancer Center (MDACC) has been performed, and a total of 129 cases with at least one time MECOM FISH positive result has been found. Other cases with 3q26 abnormality by conventional cytogenetics but negative for and/or not been confirmed for MECOM rearrangement are excluded from this study. Clinicopathologic data, including MECOM FISH test results, were collected by electronic medical chart review.
Conventional G-banded chromosomal analysis (karyotyping) has been routinely performed on unstimulated 24-h and 48-h BM aspirate cultures using standard techniques as we have reported previously [6e8] . Interphase-, metaphase-, map-back FISH and WCP have been performed by following existing laboratory protocols as reported previously [6e9] . The following probe/probe set have been employed for this study. The MECOM (EVI1) dual color, breakapart (BAP) DNA probe (#KI-10204) from Specifications 27 41,X,-Y,þ1,der(1)t(1; 14)(p13; q12)t(14; 16)(q32; q23),del(1)(p34),del(1)(q22),t(3; ?)(q26.2; ?),del(6)(q14),der(7) t(7; 8)(p21; q12),add (7)(q36),del(8)(p22),-9,dic(9; ?)(q34; ?) t(?; 11)(?; q12),psu dic(10; 1)(q26; q12),-11,del(11)(q12),-13, -14,-15,-15,der (16) 
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